AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $6,097,000 | -66.3% | 451,631 | -39.7% | 1.17% | -56.7% |
Q4 2019 | $18,094,000 | -13.8% | 748,597 | -31.4% | 2.70% | -25.4% |
Q3 2019 | $20,979,000 | -25.7% | 1,091,534 | +14.2% | 3.62% | +7.1% |
Q2 2019 | $28,251,000 | -29.2% | 956,036 | +13.8% | 3.38% | -29.6% |
Q1 2019 | $39,898,000 | -2.5% | 839,954 | -25.9% | 4.80% | -13.8% |
Q4 2018 | $40,936,000 | -14.5% | 1,133,954 | +45.9% | 5.56% | +9.5% |
Q3 2018 | $47,853,000 | +15.0% | 777,470 | +26.2% | 5.08% | +9.2% |
Q2 2018 | $41,602,000 | +42.4% | 615,870 | +14.3% | 4.65% | +45.2% |
Q1 2018 | $29,220,000 | +32.6% | 538,618 | +46.0% | 3.20% | +16.4% |
Q4 2017 | $22,036,000 | +21.4% | 368,797 | -1.2% | 2.75% | +17.8% |
Q3 2017 | $18,147,000 | -14.2% | 373,396 | -7.3% | 2.34% | +1.0% |
Q2 2017 | $21,161,000 | +19.8% | 402,674 | +3.4% | 2.31% | +12.2% |
Q1 2017 | $17,660,000 | +98.3% | 389,423 | +65.5% | 2.06% | +108.9% |
Q4 2016 | $8,906,000 | -5.3% | 235,298 | -5.6% | 0.99% | +6.9% |
Q3 2016 | $9,405,000 | +504.4% | 249,200 | +181.9% | 0.92% | +473.3% |
Q2 2016 | $1,556,000 | – | 88,400 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |